Medicine
Oseltamivir 6 mg/mL powder for oral suspension
Oseltamivir 6 mg/mL powder for oral suspension is a generic prescription medicine for oral use, made by 21 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store constituted oral suspension under refrigeration for up to 17 days at 2º…
Key facts
- Active ingredient (INN)
- Oseltamivir
- Brand
- Sold under the generic name
- Strength
- 6 mg/mL
- Dosage form
- Powder for oral suspension
- Route
- Oral
- Packs
- 1 bottle, 1 pouch, 360 mL and 22 more
- Manufacturers
- Alembic PharmaceuticalsIndiaAjanta PharmaIndiaAurobindo PharmaIndiaCamber PharmaceuticalsIndiaCiplaIndiaLupinIndiaNovadoz PharmaceuticalsIndiaStrides PharmaIndiaZydus LifesciencesIndiaA-S Medication Solutions
- Origin register
- US FDA, United States
- Storage
- Store constituted oral suspension under refrigeration for up to 17 days at 2º to 8ºC (36º to 46ºF). Do not freeze. Store dry powder at 25ºC (77ºF), excursions permitted to 15º to 30ºC (59º to 86ºF). Alternatively, store constituted oral suspension for up to 10 days at 25ºC (77ºF), excursions permitted to 15º to 30ºC (59º to 86ºF).
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J05AH02 Oseltamivir
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 14 September 2017
- Identifiers
- RxCUI 1115698DailyMed set ID 5c959361-8f08-4c65-968f-404a44422133, 82df3237-636b-7bf9-3ba0-2b476e74bf4c, 11cf45d4-0e6c-4408-bbe6-5ed94468cf2e +22NDC 31722-108, 47781-384, 72516-029 +22Application ANDA209590, ANDA208823, ANDA217303 +11
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 bottle, plastic in 1 carton / 60 mL in 1 bottle, plastic | 46708-769-60 | Alembic PharmaceuticalsIndia | 29 June 2026 |
| 1 bottle, plastic in 1 carton / 60 mL in 1 bottle, plastic | 62332-769-60 | Alembic PharmaceuticalsIndia | 29 June 2026 |
| 1 pouch in 1 carton / 1 bottle in 1 pouch / 60 mL in 1 bottle | 27241-139-09 | Ajanta PharmaIndia | 28 May 2020 |
| 1 bottle, glass in 1 carton / 60 mL in 1 bottle, glass | 59651-597-60 | Aurobindo PharmaIndia | 10 May 2024 |
| 360 mL in 1 bottle | 31722-108-60 | Camber PharmaceuticalsIndia | 28 March 2022 |
| 1 bottle in 1 carton / 60 mL in 1 bottle | 69097-904-43 | CiplaIndia | 16 January 2023 |
| 1 bottle, glass in 1 carton / 60 mL in 1 bottle, glass | 68180-678-01 | LupinIndia | 21 February 2018 |
| 60 mL in 1 bottle, glass | 72205-060-78 | Novadoz PharmaceuticalsIndia | 6 May 2022 |
| 1 bottle, glass in 1 carton / 60 mL in 1 bottle, glass | 64380-879-75 | Strides PharmaIndia | 24 October 2022 |
| 1 bottle in 1 carton / 60 mL in 1 bottle | 70710-1165-6 | Zydus LifesciencesIndia | 14 September 2017 |
| 1 bottle, glass in 1 carton / 60 mL in 1 bottle, glass | 47781-384-26 | Alvogen | 1 November 2017 |
| 1 bottle, glass in 1 carton / 60 mL in 1 bottle, glass | 69238-1273-6 | Amneal Pharmaceuticals NY | 5 March 2018 |
| 1 bottle, glass in 1 carton / 60 mL in 1 bottle, glass | 42806-363-13 | Epic Pharma | 2 August 2022 |
| 1 bottle in 1 carton / 60 mL in 1 bottle | 76282-739-52 | Exelan Pharmaceuticals | 1 December 2023 |
| 1 bottle, glass in 1 carton / 60 mL in 1 bottle, glass | 72516-029-01 | Oryza Pharmaceuticals | 19 October 2025 |
| 1 bottle in 1 carton / 60 mL in 1 bottle | 0093-8180-64 | Teva Pharmaceuticals | 10 July 2019 |
| 1 bottle, glass in 1 carton / 60 mL in 1 bottle, glass | 50090-4188-0 | A-S Medication Solutions | 14 March 2019 |
| 1 bottle in 1 carton / 60 mL in 1 bottle | 50090-4613-0 | A-S Medication Solutions | 15 October 2019 |
| 1 bottle, glass in 1 carton / 60 mL in 1 bottle, glass | 68071-3724-6 | NuCare Pharmaceuticals,Inc | 21 November 2024 |
| 1 pouch in 1 carton / 1 bottle in 1 pouch / 60 mL in 1 bottle | 68071-3960-6 | NuCare Pharmaceuticals | 28 January 2026 |
| 1 bottle in 1 carton / 60 mL in 1 bottle | 68788-7600-6 | Preferred Pharmaceuticals | 13 February 2020 |
| 1 pouch in 1 carton / 1 bottle in 1 pouch / 60 mL in 1 bottle | 68788-8123-6 | Preferred Pharmaceuticals | 10 January 2022 |
| 1 bottle, glass in 1 carton / 60 mL in 1 bottle, glass | 76420-924-60 | Asclemed | 28 February 2025 |
| 1 bottle, glass in 1 carton / 60 mL in 1 bottle, glass | 42291-567-60 | AvKARE | 26 August 2019 |
| 1 bottle, glass in 1 carton / 60 mL in 1 bottle, glass | 71205-489-60 | Proficient Rx | 19 October 2020 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Oseltamivir 6 mg/mL powder for oral suspension.
Other strengths and forms of Oseltamivir
Clinical summary
Oseltamivir is a neuraminidase inhibitor indicated for treatment of acute, uncomplicated influenza A and B in patients 2 weeks of age and older who have been symptomatic for no more than 48 hours, among other approved uses. MedsAcross supplies Oseltamivir for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about OseltamivirFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Tamiflu prescribing information (Genentech) · U.S. National Library of Medicine, DailyMed
- Tamiflu: European public assessment report (EPAR) · European Medicines Agency
- Ebilfumin: European public assessment report (EPAR) · European Medicines Agency
Need Oseltamivir 6 mg/mL powder for oral suspension for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.